Literature DB >> 15147338

Lymphopenia and neutrophilia in SARS are related to the prevailing serum cortisol.

N S Panesar, C W K Lam, M H M Chan, C K Wong, J J Y Sung.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147338      PMCID: PMC7163702          DOI: 10.1111/j.1365-2362.2004.01347.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


× No keyword cloud information.
Sir, Unexplained lymphopenia and neutrophilia occurred in patients with Severe Acute Respiratory Syndrome (SARS) [1, 2]. Although the coronavirus, implicated in SARS, may have directly caused the aforementioned; glucocorticoids can cause lymphopenia by causing the migration of lymphocytes from the peripheral circulation [3, 4, 5], and neutrophilia [3, 6] by inhibiting apoptosis [6]. Moreover, glucocorticoids are used in lymphoproliferative diseases as cytolethal agents [7]. Glucocorticoids were used in treating SARS patients, and thus lymphopenia and neutrophilia may have been drug induced. In one study [2], the prevalence of lymphopenia was 54% at admission, but only 40% of the patients were treated with steroids for the first 48 h. Therefore not all of the lymphopenia (and neutrophilia) can be ascribed to exogenous steroids. Any critical illness including SARS should provoke a stress response, and cause the normal adrenals to secrete 225–440 mg day−1 of cortisol [8], an amount that could easily cause T lymphocytes to migrate out of the peripheral circulation. We therefore questioned whether lymphopenia in SARS is reflecting the integrity of the hypothalamic‐pituitary‐adrenal (HPA) axis, and that patients without lymphopenia are perhaps adrenal insufficient [9]. In this retrospective study, we have examined the relationship between serum cortisol and white blood corpuscles (WBC) in a cohort of SARS patients with or without lymphopenia and neutrophilia. Sixty‐four patients were admitted to the Prince of Wales Hospital in Hong Kong between March and May 2003 and met modified WHO criteria for SARS. This included fever with body temperature of 38 °C or higher, cough or shortness of breath, new pulmonary infiltrates on chest radiograph, and either an exposure to a confirmed SARSpatient or a lack of response to empirical antimicrobial therapy for typical and atypical pneumonia including beta‐lactams, macrolides, fluoroquinolones, or tetracyclines. Severe Acute Respiratory Syndrome was subsequently confirmed in all patients by seropositivity and/or positive reverse transcriptase polymerase chain test for SARS‐associated coronavirus. Serum specimens from 57 patients, all collected in the morning and before the commencement of therapy, were assayed for cortisol by the electrochemiluminescence immunoassay (Roche Diagnostics Corporation, IN). The intra‐ and interassay coefficients of variation were 2·0 and 3·0%, respectively. In two patients cortisol exceeded 7220 nmol L−1 (peak stress response [8]) and were eliminated before statistical analyses. An aliquot of blood specimen was used for WBC measurements. T lymphocytes (CD3+), B lymphocytes (CD19+), helper T lymphocytes (CD3+CD4+), suppressor T lymphocytes (CD3+CD8+), and natural killer lymphocytes (CD3−CD16+ and/or CD56+) in whole blood were measured by MutliTEST™ IMK Kit along with TruCOUNT Tubes (Becton Dickinson, San Diego, CA) using a 4‐colour FACSCalibur flow cytometer (Becton Dickinson). The method had 10% imprecision. Lymphopenia was defined as lymphocyte count < 19%[normal range (NR) 19–47%] and neutrophilia as neutrophil count > 73% (NR 41–73%) of the total WBC. The frequencies of lymphopenia or neutrophilia relative to cortisol deficient (< 414 nmol L−1[10]) or replete state were tested by 2 × 2 χ2 test. All data were analyzed using the Statistica software (StatSoft, Tulsa, OK). We found that serum cortisol correlated positively with neutrophils, and negatively with monocytes and lymphocytes. With lymphocyte subsets, cortisol correlated negatively with suppressor CD8+ cells, B lymphocytes and helper CD4+ cells (all correlations were significant with P < 0·05, see Table 1). In 54 out of 59 patients lymphopenia concurred with neutrophilia, but lymphocytes were not inversely correlated with neutrophils. Cortisol was significantly higher in the lymphopenic compared with nonlymphopenic patients (P < 0·005; Mann–Whitney U‐test) and the neutrophilic compared with non‐neutrophilic patients (P < 0·0001; Mann–Whitney U‐test) (Figure 1). The frequency of neutrophilia (24/50; Pearson χ2, P = 0·011) and lymphopenia (23/50; Pearson χ2, P = 0·184) were confined to cortisol replete state (see Figure 1 inset).
Table 1

Correlation of blood cortisol with total white blood corpuscle and its various cellular components

WBC and differentials (n = 49) Lymphocyte subsets (n = 34)
WBCNeutrosLymphosMonosCD3+ CD4+ CD8+ NKB
Cortisol0·220·31 * −0·36 * −0·30 * −0·43 * −0·35 * −0·56 * −0·05−0·46 *

Correlations coefficients are significant at P < 0·05.

Neutros, neutrophils; Lymphos, lymphocytes; Monos, monocytes; NK, natural killer cells.

Figure 1

Serum cortisol in Severe Acute Respiratory Syndrome patients with or without lymphopenia or neutrophilia. The little squares represent the median, the large rectangles represent the 25–75th percentile range and the error bars represent the maximum to minimum range. The Mann–Whitney U‐test comparisons between different groups are depicted by asterisks. The insets show 2 × 2 frequency tables of cortisol deficiency (def.) (yes or no) against lymphopenia (Pearson χ2, P = 0·184) or neutrophilia (Pearson χ2, P = 0·011) status (yes or no).

Correlation of blood cortisol with total white blood corpuscle and its various cellular components Correlations coefficients are significant at P < 0·05. Neutros, neutrophils; Lymphos, lymphocytes; Monos, monocytes; NK, natural killer cells. Serum cortisol in Severe Acute Respiratory Syndrome patients with or without lymphopenia or neutrophilia. The little squares represent the median, the large rectangles represent the 25–75th percentile range and the error bars represent the maximum to minimum range. The Mann–Whitney U‐test comparisons between different groups are depicted by asterisks. The insets show 2 × 2 frequency tables of cortisol deficiency (def.) (yes or no) against lymphopenia (Pearson χ2, P = 0·184) or neutrophilia (Pearson χ2, P = 0·011) status (yes or no). This study has shown (i) significant correlations between serum cortisol and numbers of lymphocytes and neutrophils and (ii) that SARS patients with lymphopenia and neutrophilia had significantly higher cortisol than those without. A critical illness such as SARS should cause secretion of 225–440 mg day−1 of cortisol with a blood concentration of 883–7220 nmol L−1[8]. The patients exhibiting lymphopenia and neutrophilia had cortisol in this range, which may explain their WBC status. O’Donnell et al. suggested that apoptosis may explain lymphopenia in SARS [11], based on their findings of lymphopenia and neutrophilia in children with severe respiratory syncytial virus disease. It is difficult to explain why viral infection causes apoptosis in lymphocytes, but not in neutrophils. As stated earlier, cortisol action can explain both lymphopenia and neutrophilia. Short‐duration high‐dose glucocorticoid therapy is ineffective in acute respiratory distress syndrome [8], and steroid usage in SARS has been questioned [12]. Admittedly, the outbreak of SARS caught the medical community totally unprepared in Hong Kong, with the inadvertent use of Ribavarin and steroid therapy to alleviate patients’ suffering. It is difficult to say if the patients with lymphopenia and neutrophilia fared any better than those without and vice versa, but it is noteworthy that patients admitted to Intensive Care Units or who eventually died had a significantly higher neutrophil count [1]. Whether the neutrophilia in this group of patients was a reflection of steroid treatment remains unanswered. In retrospect, it might be judicious to keep an eye on a patient's HPA axis. The need for steroids should never arise if the HPA axis is functioning normally, and if steroids are at all required they should be reserved for patients with adrenal insufficiency. This, from our study, may be reflected by the lymphopenia and neutrophilia.
  12 in total

Review 1.  Corticosteroid insufficiency in acutely ill patients.

Authors:  Mark S Cooper; Paul M Stewart
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

Review 2.  Glucocorticoids and acute lung injury.

Authors:  B Taylor Thompson
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

3.  The use of corticosteroids in SARS.

Authors:  Yuji Oba
Journal:  N Engl J Med       Date:  2003-05-15       Impact factor: 91.245

4.  SARS: understanding the coronavirus: apoptosis may explain lymphopenia of SARS.

Authors:  Roddy O'Donnell; Robert C Tasker; Michael F E Roe
Journal:  BMJ       Date:  2003-09-13

5.  A major outbreak of severe acute respiratory syndrome in Hong Kong.

Authors:  Nelson Lee; David Hui; Alan Wu; Paul Chan; Peter Cameron; Gavin M Joynt; Anil Ahuja; Man Yee Yung; C B Leung; K F To; S F Lui; C C Szeto; Sydney Chung; Joseph J Y Sung
Journal:  N Engl J Med       Date:  2003-04-07       Impact factor: 91.245

6.  A comparison of the effects of oral prednisone and inhaled beclomethasone dipropionate on circulating leukocytes.

Authors:  R G Cameron; P N Black; C Braan; P J Browett
Journal:  Aust N Z J Med       Date:  1996-12

7.  Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.

Authors:  Christopher M Booth; Larissa M Matukas; George A Tomlinson; Anita R Rachlis; David B Rose; Hy A Dwosh; Sharon L Walmsley; Tony Mazzulli; Monica Avendano; Peter Derkach; Issa E Ephtimios; Ian Kitai; Barbara D Mederski; Steven B Shadowitz; Wayne L Gold; Laura A Hawryluck; Elizabeth Rea; Jordan S Chenkin; David W Cescon; Susan M Poutanen; Allan S Detsky
Journal:  JAMA       Date:  2003-05-06       Impact factor: 56.272

Review 8.  Glucocorticosteroid therapy: mechanisms of action and clinical considerations.

Authors:  A S Fauci; D C Dale; J E Balow
Journal:  Ann Intern Med       Date:  1976-03       Impact factor: 25.391

9.  Prednisolone levels in plasma and leukemia cells during therapy of chronic lymphocytic leukemia.

Authors:  N S Panesar; C C Bird; B E Roberts; J A Child
Journal:  J Pharm Sci       Date:  1984-01       Impact factor: 3.534

10.  Prednisone-induced alterations of circulating human lymphocyte subsets.

Authors:  J D Slade; B Hepburn
Journal:  J Lab Clin Med       Date:  1983-03
View more
  14 in total

1.  Bcl-xL inhibits T-cell apoptosis induced by expression of SARS coronavirus E protein in the absence of growth factors.

Authors:  Yu Yang; Zeyu Xiong; Sheng Zhang; Yan Yan; Justin Nguyen; Bernard Ng; Huifang Lu; John Brendese; Fan Yang; Hong Wang; Xiao-Feng Yang
Journal:  Biochem J       Date:  2005-11-15       Impact factor: 3.857

Review 2.  A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19).

Authors:  Celestin Danwang; Francky Teddy Endomba; Jan René Nkeck; Dominic Leandry Angong Wouna; Annie Robert; Jean Jacques Noubiap
Journal:  Biomark Res       Date:  2020-08-31

3.  Recruiting the innate immune system with GM-CSF to fight viral diseases, including West Nile Virus encephalitis and COVID-19.

Authors:  Huntington Potter; Timothy D Boyd; Penny Clarke; Victoria S Pelak; Kenneth L Tyler
Journal:  F1000Res       Date:  2020-05-11

4.  Th2 predominance and CD8+ memory T cell depletion in patients with severe acute respiratory syndrome.

Authors:  Jia-Ling Huang; Jian Huang; Zhao-Hui Duan; Jing Wei; Jun Min; Xiao-Hong Luo; Jian-Guo Li; Wei-Ping Tan; Li-Zhi Wu; Ran-Yi Liu; Yan Li; Jing Shao; Bi-Jun Huang; Yi-Xin Zeng; Wenlin Huang
Journal:  Microbes Infect       Date:  2005-02-24       Impact factor: 2.700

5.  T-cell dysregulation in COVID-19.

Authors:  Bahire Kalfaoglu; José Almeida-Santos; Chanidapa Adele Tye; Yorifumi Satou; Masahiro Ono
Journal:  Biochem Biophys Res Commun       Date:  2020-11-07       Impact factor: 3.575

Review 6.  Effects of COVID-19 on the Nervous System.

Authors:  Costantino Iadecola; Josef Anrather; Hooman Kamel
Journal:  Cell       Date:  2020-08-19       Impact factor: 41.582

Review 7.  [Systemic consequences and clinical aspects of SARS-CoV-2 infection].

Authors:  Sigurd F Lax; Kristijan Skok; Peter M Zechner; Lisa Setaffy; Harald H Kessler; Norbert Kaufmann; Klaus Vander; Natalija Cokić; Urša Maierhofer; Ute Bargfrieder; Michael Trauner
Journal:  Pathologe       Date:  2021-02-11       Impact factor: 1.011

Review 8.  Is lymphopenia different between SARS and COVID-19 patients?

Authors:  Shaomin Yan; Guang Wu
Journal:  FASEB J       Date:  2021-02       Impact factor: 5.834

9.  Clinical stage molecule PT150 is a modulator of glucocorticoid and androgen receptors with antiviral activity against SARS-CoV-2.

Authors:  Neil D Theise; Anthony R Arment; Dimple Chakravarty; John M H Gregg; Ira M Jacobson; Kie Hoon Jung; Sujit S Nair; Ashutosh K Tewari; Archie W Thurston; John Van Drie; Jonna B Westover
Journal:  Cell Cycle       Date:  2020-12-11       Impact factor: 4.534

10.  What caused lymphopenia in SARS and how reliable is the lymphokine status in glucocorticoid-treated patients?

Authors:  N S Panesar
Journal:  Med Hypotheses       Date:  2008-04-29       Impact factor: 1.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.